Supplementary Data from Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non–Small Cell Lung Cancer

Sandra Ortiz‐Cuaran, Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazières, Camille Léonce, Cécile Jovelet, Anne Pradines, Virginie Avrillon, Washington R. Chumbi Flores, Ludovic Lacroix, Yohann Loriot, Virginie Westeel, Maud Ngo‐Camus, Claire Tissot, C. Raynaud, Radj Gervais, Étienne Brain, I. Monnet, Etienne Giroux‐Leprieur, Caroline Caramella, Céline Mahier‐Ait Oukhatar, Natalie Hoog-Labouret, Frank de Kievit, Karen Howarth, Clive Morris, Emma Green, Luc Friboulet, Sylvie Chabaud, Jean‐François Guichou, M. Pérol, Benjamin Besse, Jean Yves Blay, Pierre Saintigny, David Planchard (2023). Supplementary Data from Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non–Small Cell Lung Cancer. , DOI: https://doi.org/10.1158/1078-0432.22478981.v1.